Drug information provided by: Merative, Micromedex®
Elivaldogene autotemcel injection is used to treat early, active cerebral adrenoleukodystrophy (CALD) in boys 4 to 17 years of age.
Cerebral adrenoleukodystrophy (CALD) is a genetic disease caused by mutations in the ABCD1 gene that lead to the buildup of very long fatty acids (VLCFAs) in the brain. These fatty acids may cause brain and nerve damage. The damage can be seen on magnetic resonance imaging (MRI) scans of the brain. Elivaldogene autotemcel injection is recommended if the damage is determined to be early and if the brain disease is active. It will help the body to break down the fatty acids to slow the progression of damage to the brain and slow the decline in nerve function.
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.